greeksoup/ stock research

Albertsons Companies, Inc.: Q3 FY2025 earnings call

What management said about Q3 FY2025, from the documents filed with the SEC on 7 January 2026: press release. Guidance figures: 2 lowered, 1 kept. The quarter’s numbers.

Key takeaways

  • Sales rose 1.9% on identical sales: Net sales and other revenue reached $19,123.7 million, up 1.9%. Identical sales rose 2.4%, with pharmacy the primary driver. Store closures and lower fuel sales partly offset the increase. Source
  • Net income down, adjusted EPS up: Net income was $293.3 million, or $0.55 per share, against $400.6 million, or $0.69, a year earlier. That year included an $81.0 million discrete state tax benefit. Adjusted EPS was $0.72 against $0.71. Source
  • Gross margin rate fell 50 basis points: Gross margin rate was 27.4%, against 27.9%. Excluding fuel and LIFO expense, the decline was 55 basis points. Management cited delivery and handling costs from digital growth, and pharmacy mix, which carries a lower margin rate. Source
  • Government shutdown reduced identical sales: Management estimated the temporary government shutdown and related delayed SNAP funding cut identical sales by about 10 to 20 basis points in the quarter. Source
  • Medicare drug program lowers pharmacy sales: Fiscal 2025 identical sales carry a 16 to 18 basis point impact from the Medicare negotiation program, or 65 to 70 basis points in the fourth quarter, as pharmacy sales fall. Source
  • Buybacks reached $1,361.6 million: Repurchases for the first 40 weeks totalled $1,361.6 million, including the $750.0 million accelerated share repurchase, under the $2.75 billion authorization. Source
  • Technology and AI reshaping operations: Management said investments in technology and AI are changing how the company operates and serves customers, citing smarter decisions, efficiency and personalized experiences. Source

“In the third quarter, we delivered solid results and continued to advance our strategic priorities,”

Susan Morris, Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Identical sales growth Sourcefiscal 20252.2% to 2.5%Lowered from 2.2% to 2.75%
Adjusted EBITDA Sourcefiscal 2025$3.825 billion to $3.875 billion
Adjusted net income per Class A common share Sourcefiscal 2025$2.08 to $2.16 per share
Effective income tax rate Sourcefiscal 202523% to 24%Lowered from 23.5% to 24.5%
Capital expenditures Sourcefiscal 2025$1.8 billion to $1.9 billionKept

What changed from last quarter

  • Guidance lowered: Fiscal 2025 identical sales range top end cut to 2.5% from 2.75%; bottom end unchanged at 2.2%. Source
  • Guidance lowered: Fiscal 2025 effective income tax rate range lowered to 23% to 24% from 23.5% to 24.5%. Source
  • Guidance kept: Fiscal 2025 capital expenditure range of $1.8 billion to $1.9 billion is stated as unchanged. Source
  • New: Senior unsecured notes issued November 10, 2025: $700.0 million due 2031 and $800.0 million due 2034. Source

Results and growth drivers

  • Sales rose 1.9% on identical sales: Net sales and other revenue reached $19,123.7 million, up 1.9%. Identical sales rose 2.4%, with pharmacy the primary driver. Store closures and lower fuel sales partly offset the increase. Source
  • Net income down, adjusted EPS up: Net income was $293.3 million, or $0.55 per share, against $400.6 million, or $0.69, a year earlier. That year included an $81.0 million discrete state tax benefit. Adjusted EPS was $0.72 against $0.71. Source
  • Adjusted EBITDA fell to $1,038.7 million: Adjusted EBITDA was $1,038.7 million, or 5.4% of net sales and other revenue, against $1,065.1 million and 5.7% a year earlier. Source

Gross margin and operating costs

  • Gross margin rate fell 50 basis points: Gross margin rate was 27.4%, against 27.9%. Excluding fuel and LIFO expense, the decline was 55 basis points. Management cited delivery and handling costs from digital growth, and pharmacy mix, which carries a lower margin rate. Source
  • Selling and administrative ratio declined: Selling and administrative expenses were 24.9% of net sales, against 25.1%. Excluding fuel, the ratio fell 33 basis points, from sales leverage on employee costs and lower merger-related costs, partly offset by business transformation costs. Source
  • Customer value investments continue: Management continues incremental investments in the customer value proposition, funded by benefits from productivity initiatives. Source

“Growth in our digital and pharmacy channels, combined with disciplined execution and targeted investments, is strengthening our value proposition and positioning us for success.”

Susan Morris, Chief Executive Officer

Products, customers and stores

  • In-store pharmacy count edged lower: In-store pharmacies numbered 1,708 at quarter end, against 1,720 at the second quarter end. Source
  • Store count fell to 2,243: Stores at quarter end totalled 2,243, against 2,273 a year earlier. Store closures and lower fuel sales reduced net sales. Source
  • Digital and loyalty both grew: Digital sales rose 21% in the quarter. Loyalty members increased 12% to 49.8 million. Source

Demand and external pressures

  • Government shutdown reduced identical sales: Management estimated the temporary government shutdown and related delayed SNAP funding cut identical sales by about 10 to 20 basis points in the quarter. Source
  • Medicare drug program lowers pharmacy sales: Fiscal 2025 identical sales carry a 16 to 18 basis point impact from the Medicare negotiation program, or 65 to 70 basis points in the fourth quarter, as pharmacy sales fall. Source
  • Identical sales definition excludes fuel: Identical sales compare same-period stores on a daily basis, include direct-to-consumer digital sales, and exclude fuel sales. Source

“As we look ahead, I am confident that our modernized technology foundation, relentless focus on productivity, and commitment to innovation will enable us to deliver sustainable long-term value for our customers, associates, and shareholders.”

Susan Morris, Chief Executive Officer

Capital, cash and shareholder returns

  • Capital spending through 40 weeks: Capital expenditures were $1,412.8 million in the first 40 weeks, mainly 74 remodels, five new stores, and digital and technology investment. Source
  • Buybacks reached $1,361.6 million: Repurchases for the first 40 weeks totalled $1,361.6 million, including the $750.0 million accelerated share repurchase, under the $2.75 billion authorization. Source
  • Notes issued to refinance 2026 maturity: Issued $700.0 million of 2031 notes and $800.0 million of 2034 notes. Proceeds redeemed the $750.0 million 3.250% notes due March 2026 and repaid part of the ABL borrowings. Source
  • Operating cash flow lower than last year: Net cash provided by operating activities was $1,649.6 million for 40 weeks, against $1,922.1 million a year earlier. Source

Strategy, technology and merger costs

  • Technology and AI reshaping operations: Management said investments in technology and AI are changing how the company operates and serves customers, citing smarter decisions, efficiency and personalized experiences. Source
  • Customers for Life transformation costs: Business transformation costs were $35.6 million in the quarter and $109.2 million in 40 weeks, mainly consulting fees for the Customers for Life strategy. Source
  • Merger-related costs fell year on year: Merger-related costs were $23.1 million in the quarter, against $61.1 million a year earlier, mainly legal, advisor and retention expense tied to the merger. Source

Coming up, as management said on 7 January 2026

  • ASR final settlement in Q1 2026: Remaining shares under the accelerated share repurchase will be delivered at final settlement, expected in the first calendar quarter of 2026. Source
  • Quarterly dividend payment February 6, 2026: The next quarterly dividend of $0.15 per share is payable February 6, 2026 to holders of record at the close of business January 23, 2026. Source

Figures management reported

FigureReported
Comparable sales (identical sales) Source+2.4%
Gross margin Source27.4% (prior-year quarter 27.9%)
Inventory Source$5,496.7 million at November 29, 2025 (February 22, 2025: $4,989.0 million)
Store openings and closings Sourcefive new stores opened in first 40 weeks; 2,243 stores at quarter end (2,273 a year earlier)
E-commerce share Sourcenot stated; digital sales up 21%

Risks management discussed

  • Operational: Management said productivity benefits only partly offset rising wage rates and other inflationary pressures on operating expenses. Source
  • Regulatory: Litigation and retention costs tied to the terminated merger were reported as adjustment items for the quarter and the first 40 weeks. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.